Severe inflammatory disease activity 14 months after cessation of Natalizumab in a patient with Leber’s optic neuropathy and multiple sclerosis – a case report

por Holmøy, Trygve, Beiske, Antonie G., Zarnovicky, Svetozar, Myro, Aija Zuleron, Røsjø, Egil, Kerty, Emilia
Publicado 2016

Alpha-tocopherol and MRI Outcomes in Multiple Sclerosis – Association and Prediction

por Løken-Amsrud, Kristin I., Myhr, Kjell-Morten, Bakke, Søren J., Beiske, Antonie G., Bjerve, Kristian S., Bjørnarå, Bård T., Hovdal, Harald, Lilleås, Finn, Midgard, Rune, Pedersen, Tom, Benth, Jūratė Šaltytė, Torkildsen, Øivind, Wergeland, Stig, Holmøy, Trygve
Publicado 2013

No association of tobacco use and disease activity in multiple sclerosis

por Kvistad, Silje, Myhr, Kjell-Morten, Holmøy, Trygve, Benth, Jūratė Šaltytė, Løken-Amsrud, Kristin I., Wergeland, Stig, Beiske, Antonie G., Bjerve, Kristian S., Hovdal, Harald, Lilleås, Finn, Midgard, Rune, Pedersen, Tom, Bakke, Søren J., Torkildsen, Øivind
Publicado 2016

Inflammation Markers in Multiple Sclerosis: CXCL16 Reflects and May Also Predict Disease Activity

por Holmøy, Trygve, Løken-Amsrud, Kristin Ingeleiv, Bakke, Søren Jacob, Beiske, Antonie G., Bjerve, Kristian S., Hovdal, Harald, Lilleås, Finn, Midgard, Rune, Pedersen, Tom, Šaltytė Benth, Jutrate, Torkildsen, Øivind, Wergeland, Stig, Myhr, Kjell-Morten, Michelsen, Annika E., Aukrust, Pål, Ueland, Thor
Publicado 2013